Subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy

Braghadheeswar Thyagarajan; Ankur Kalra; Alefiyah Rajabali; Jill B. Whelan; Elad Anter

doi:10.15420/usc.2016:7:2

Subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy

Braghadheeswar Thyagarajan
, Ankur Kalra^*
, Alefiyah Rajabali
, Jill B. Whelan
, Elad Anter

^*Corresponding author for this work

Saint Barnabas Medical Center
Harvard University

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Abstract

Atrial fibrillation is the most common arrhythmia in patients with hypertrophic cardiomyopathy. Patients with atrial fibrillation in hypertrophic cardiomyopathy are at an increased risk of stroke compared with patients without hypertrophic cardiomyopathy. While the burden of clinicallymanifest atrial fibrillation and its management with anticoagulation for stroke prevention in hypertrophic cardiomyopathy patients have been described, little is known about the prevalence, clinical outcomes and management of subclinical episodes of atrial fibrillation in patients with hypertrophic cardiomyopathy. This brief review sheds light on the concept of subclinical atrial fibrillation in hypertrophic cardiomyopathy patients, and discusses its diagnostic and management dilemmas in the era of burgeoning cardiac rhythm management devices utilization.

Original language	English
Pages (from-to)	75-77
Number of pages	3
Journal	US Cardiology Review
Volume	10
Issue number	2
DOIs	https://doi.org/10.15420/usc.2016:7:2
State	Published - 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Atrial fibrillation
Hypertrophic cardiomyopathy
Subclinical
Thromboembolism

Access to Document

10.15420/usc.2016:7:2

Cite this

@article{d68ffe56b97649ecb6704a8e64fd4b27,

title = "Subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy",

abstract = "Atrial fibrillation is the most common arrhythmia in patients with hypertrophic cardiomyopathy. Patients with atrial fibrillation in hypertrophic cardiomyopathy are at an increased risk of stroke compared with patients without hypertrophic cardiomyopathy. While the burden of clinicallymanifest atrial fibrillation and its management with anticoagulation for stroke prevention in hypertrophic cardiomyopathy patients have been described, little is known about the prevalence, clinical outcomes and management of subclinical episodes of atrial fibrillation in patients with hypertrophic cardiomyopathy. This brief review sheds light on the concept of subclinical atrial fibrillation in hypertrophic cardiomyopathy patients, and discusses its diagnostic and management dilemmas in the era of burgeoning cardiac rhythm management devices utilization.",

keywords = "Atrial fibrillation, Hypertrophic cardiomyopathy, Subclinical, Thromboembolism",

author = "Braghadheeswar Thyagarajan and Ankur Kalra and Alefiyah Rajabali and Whelan, \{Jill B.\} and Elad Anter",

note = "Publisher Copyright: {\textcopyright} RADCLIFFE CARDIOLOGY 2016.",

year = "2016",

doi = "10.15420/usc.2016:7:2",

language = "אנגלית",

volume = "10",

pages = "75--77",

journal = "US Cardiology Review",

issn = "1758-3896",

publisher = "Radcliffe Medical Media",

number = "2",

}

TY - JOUR

T1 - Subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy

AU - Thyagarajan, Braghadheeswar

AU - Kalra, Ankur

AU - Rajabali, Alefiyah

AU - Whelan, Jill B.

AU - Anter, Elad

N1 - Publisher Copyright: © RADCLIFFE CARDIOLOGY 2016.

PY - 2016

Y1 - 2016

N2 - Atrial fibrillation is the most common arrhythmia in patients with hypertrophic cardiomyopathy. Patients with atrial fibrillation in hypertrophic cardiomyopathy are at an increased risk of stroke compared with patients without hypertrophic cardiomyopathy. While the burden of clinicallymanifest atrial fibrillation and its management with anticoagulation for stroke prevention in hypertrophic cardiomyopathy patients have been described, little is known about the prevalence, clinical outcomes and management of subclinical episodes of atrial fibrillation in patients with hypertrophic cardiomyopathy. This brief review sheds light on the concept of subclinical atrial fibrillation in hypertrophic cardiomyopathy patients, and discusses its diagnostic and management dilemmas in the era of burgeoning cardiac rhythm management devices utilization.

AB - Atrial fibrillation is the most common arrhythmia in patients with hypertrophic cardiomyopathy. Patients with atrial fibrillation in hypertrophic cardiomyopathy are at an increased risk of stroke compared with patients without hypertrophic cardiomyopathy. While the burden of clinicallymanifest atrial fibrillation and its management with anticoagulation for stroke prevention in hypertrophic cardiomyopathy patients have been described, little is known about the prevalence, clinical outcomes and management of subclinical episodes of atrial fibrillation in patients with hypertrophic cardiomyopathy. This brief review sheds light on the concept of subclinical atrial fibrillation in hypertrophic cardiomyopathy patients, and discusses its diagnostic and management dilemmas in the era of burgeoning cardiac rhythm management devices utilization.

KW - Atrial fibrillation

KW - Hypertrophic cardiomyopathy

KW - Subclinical

KW - Thromboembolism

UR - https://www.scopus.com/pages/publications/85002849697

U2 - 10.15420/usc.2016:7:2

DO - 10.15420/usc.2016:7:2

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:85002849697

SN - 1758-3896

VL - 10

SP - 75

EP - 77

JO - US Cardiology Review

JF - US Cardiology Review

IS - 2

ER -

Subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this